Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Traditional risk factors for essential hypertension: analysis of their specific combinations in the EPIC-Potsdam cohort.

Andriolo V, Dietrich S, Knüppel S, Bernigau W, Boeing H.

Sci Rep. 2019 Feb 6;9(1):1501. doi: 10.1038/s41598-019-38783-5.

2.

Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study.

Molnos S, Wahl S, Haid M, Eekhoff EMW, Pool R, Floegel A, Deelen J, Much D, Prehn C, Breier M, Draisma HH, van Leeuwen N, Simonis-Bik AMC, Jonsson A, Willemsen G, Bernigau W, Wang-Sattler R, Suhre K, Peters A, Thorand B, Herder C, Rathmann W, Roden M, Gieger C, Kramer MHH, van Heemst D, Pedersen HK, Gudmundsdottir V, Schulze MB, Pischon T, de Geus EJC, Boeing H, Boomsma DI, Ziegler AG, Slagboom PE, Hummel S, Beekman M, Grallert H, Brunak S, McCarthy MI, Gupta R, Pearson ER, Adamski J, 't Hart LM.

Diabetologia. 2018 Jan;61(1):117-129. doi: 10.1007/s00125-017-4436-7. Epub 2017 Oct 25.

3.

No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC).

Bergmann MM, Hernandez V, Bernigau W, Boeing H, Chan SS, Luben R, Khaw KT, van Schaik F, Oldenburg B, Bueno-de-Mesquita B, Overvad K, Palli D, Masala G, Carbonnel F, Boutron-Ruault MC, Olsen A, Tjonneland A, Kaaks R, Katzke V, Riboli E, Hart AR.

Eur J Clin Nutr. 2017 Apr;71(4):566. doi: 10.1038/ejcn.2017.16. No abstract available.

PMID:
28377581
4.

No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC).

Bergmann MM, Hernandez V, Bernigau W, Boeing H, Chan SS, Luben R, Khaw KT, van Schaik F, Oldenburg B, Bueno-de-Mesquita B, Overvad K, Palli D, Masala G, Carbonnel F, Boutron-Ruault MC, Olsen A, Tjonneland A, Kaaks R, Katzke V, Riboli E, Hart AR.

Eur J Clin Nutr. 2017 Apr;71(4):512-518. doi: 10.1038/ejcn.2016.271. Epub 2017 Jan 25. Erratum in: Eur J Clin Nutr. 2017 Apr;71(4):566.

5.

Modulation of circulating vasoactive peptides and extracellular matrix proteins are two novel mechanisms in the cardioprotective action of acarbose.

Rudovich N, Pivovarova O, Bernigau W, Sparwasser A, Tacke C, Murahovshi V, Mertes G, Birkenfeld AL, Bergmann A, Weickert MO, Pfeiffer AF.

Minerva Endocrinol. 2016 Dec;41(4):456-68. Epub 2016 Mar 23.

6.

Hepatic insulin clearance is closely related to metabolic syndrome components.

Pivovarova O, Bernigau W, Bobbert T, Isken F, Möhlig M, Spranger J, Weickert MO, Osterhoff M, Pfeiffer AF, Rudovich N.

Diabetes Care. 2013 Nov;36(11):3779-85. doi: 10.2337/dc12-1203. Epub 2013 Sep 11.

7.

Acarbose treatment enhances mid-regional pro-atrial natriuretic peptide concentrations in non-diabetic individuals: further evidence for a common cardiometabolic pathway?

Rudovich N, Pivovarova O, Traberth A, Sparwasser A, Weickert MO, Bernigau W, Birkenfeld AL, Arafat AM, Bergmann A, Pfeiffer AF.

Diabetologia. 2012 Dec;55(12):3392-5. doi: 10.1007/s00125-012-2724-9. Epub 2012 Sep 20. No abstract available.

PMID:
22990716
8.

Effects of acarbose treatment on markers of insulin sensitivity and systemic inflammation.

Rudovich NN, Weickert MO, Pivovarova O, Bernigau W, Pfeiffer AF.

Diabetes Technol Ther. 2011 Jun;13(6):615-23. doi: 10.1089/dia.2010.0235. Epub 2011 Apr 13.

PMID:
21488802

Supplemental Content

Loading ...
Support Center